FRI0141 Retention Rate and Discontinuation Due to Efficacy and Safety in Japanese Patients with Rheumatoid Arthritis Receiving Adalimumab Therapy: A Multicenter Study
FRI0141 Retention Rate and Discontinuation Due to Efficacy and Safety in Japanese Patients with Rheumatoid Arthritis Receiving Adalimumab Therapy: A Multicenter Study